Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (4470)	3/24/1998 11:06:00 PM
From: Rocketman	Respond to of 9719

Peter, Norian and CBMI/Stryker are targeting two different types of applications at this time. Norian targets crush type fractures of trabecular bone (fibrous spongy stuff inside the ends of bones). Whereas CBMI is targeting cortical bone, which is the hard type of bone that is on the surface of bones, and which constitutes the central bone in a long structural bone. Cortical breaks are the typical broken arm breaks that heal with a cast. Trabecular crush fractures are where the fibrous end of a bone is broken and crushed into lots of pieces and doesn't tend to heal with just a simple casting. I think that they can actually help each other by drawing more attention to the use of advanced materials for orthopedic repair. Rman